Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Raw Materials (2020 - 2025)

Historic Raw Materials for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $3.9 million.

  • Maxcyte's Raw Materials fell 3052.71% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 3052.71%. This contributed to the annual value of $4.7 million for FY2024, which is 1715.84% down from last year.
  • Latest data reveals that Maxcyte reported Raw Materials of $3.9 million as of Q3 2025, which was down 3052.71% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Maxcyte's Raw Materials peaked at $6.0 million during Q1 2023, and registered a low of $1.6 million during Q3 2021.
  • Moreover, its 5-year median value for Raw Materials was $5.0 million (2022), whereas its average is $4.6 million.
  • Per our database at Business Quant, Maxcyte's Raw Materials soared by 22417.53% in 2022 and then tumbled by 3052.71% in 2025.
  • Over the past 5 years, Maxcyte's Raw Materials (Quarter) stood at $2.7 million in 2021, then soared by 110.54% to $5.7 million in 2022, then increased by 0.76% to $5.7 million in 2023, then dropped by 17.16% to $4.7 million in 2024, then decreased by 18.13% to $3.9 million in 2025.
  • Its last three reported values are $3.9 million in Q3 2025, $4.1 million for Q2 2025, and $4.5 million during Q1 2025.